Fabrizio Galimberti

1.3k total citations
44 papers, 902 citations indexed

About

Fabrizio Galimberti is a scholar working on Molecular Biology, Pathology and Forensic Medicine and Dermatology. According to data from OpenAlex, Fabrizio Galimberti has authored 44 papers receiving a total of 902 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 9 papers in Pathology and Forensic Medicine and 9 papers in Dermatology. Recurrent topics in Fabrizio Galimberti's work include Hedgehog Signaling Pathway Studies (6 papers), Cancer-related Molecular Pathways (5 papers) and Inflammatory Myopathies and Dermatomyositis (5 papers). Fabrizio Galimberti is often cited by papers focused on Hedgehog Signaling Pathway Studies (6 papers), Cancer-related Molecular Pathways (5 papers) and Inflammatory Myopathies and Dermatomyositis (5 papers). Fabrizio Galimberti collaborates with scholars based in United States, Canada and Türkiye. Fabrizio Galimberti's co-authors include Ethan Dmitrovsky, Anthony P. Fernandez, Vincent A. Memoli, Sarah J. Freemantle, Konstantin H. Dragnev, Xi Liu, David Sekula, James DiRenzo, Lorenzo F. Sempere and Candice C. Black and has published in prestigious journals such as Cancer Research, Oncogene and Clinical Cancer Research.

In The Last Decade

Fabrizio Galimberti

40 papers receiving 888 citations

Peers

Countries citing papers authored by Fabrizio Galimberti

Since Specialization

Citations

This map shows the geographic impact of Fabrizio Galimberti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fabrizio Galimberti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fabrizio Galimberti more than expected).

Fields of papers citing papers by Fabrizio Galimberti

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fabrizio Galimberti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fabrizio Galimberti. The network helps show where Fabrizio Galimberti may publish in the future.

Co-authorship network of co-authors of Fabrizio Galimberti

This figure shows the co-authorship network connecting the top 25 collaborators of Fabrizio Galimberti. A scholar is included among the top collaborators of Fabrizio Galimberti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fabrizio Galimberti. Fabrizio Galimberti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Meta-analysis of randomized controlled trials evaluating the association between magnitude and duration of apolipoprotein-B lowering and cardiovascular risk reduction among different lipid-lowering therapies 2023 ·Atherosclerosis ·Fabrizio Galimberti, Allan D. Sniderman, Alberico L. Catapano, Brian A. Ference	1
2	Experimental Characterization of Rotary Transformer Prototypes for Wireless Power Transfer on Helicopters 2023 ·Virtual Community of Pathological Anatomy (University of Castilla La Mancha) ·(unknown), (unknown), (unknown), Fabrizio Galimberti, Marco Mauri, Maria Stefania Carmeli, Francesco Castelli Dezza	0
3	Dermatomyositis and malignancy: should all patients with dermatomyositis undergo malignancy screening? 2021 ·Annals of Translational Medicine ·Urmi Khanna, Fabrizio Galimberti, Yumeng Li, Anthony P. Fernandez	19
4	Evidence-based best practice advice for patients treated with systemic immunosuppressants in relation to COVID-19 2020 ·Clinics in Dermatology ·Fabrizio Galimberti, Jeffrey D. McBride, (unknown), Yumeng Li, Joshua Fox, Michael Abrouk, (unknown), Robert S. Kirsner	12
5	US Dermatology Resident Responses about the COVID-19 Pandemic: Results from a Nationwide Survey 2020 ·Southern Medical Journal ·(unknown), Fabrizio Galimberti, Michael Abrouk, Robert S. Kirsner	12
6	Online availability of neurotoxin and injectable cosmetics 2020 ·Journal of the American Academy of Dermatology ·Yumeng Li, Fabrizio Galimberti, (unknown)	3
7	A influência do ciclo menstrual na dor aguda e persistente após colecistectomia laparoscópica 2018 ·Brazilian Journal of Anesthesiology ·Sinem Sarı, Betül Kozanhan, (unknown), Aykut Soyder, (unknown), Fabrizio Galimberti, Daniel I. Sessler, Alparslan Turan	4
8	540 Intravenous immunoglobulin is an effective treatment for refractory cutaneous dermatomyositis 2018 ·Journal of Investigative Dermatology ·Fabrizio Galimberti, (unknown), (unknown), Soumya Chatterjee, Anthony P. Fernandez	3
9	Malignancy-associated dermatomyositis: Retrospective case–control study from a single tertiary care center 2018 ·Journal of the American Academy of Dermatology ·(unknown), (unknown), Fabrizio Galimberti, Carmen E. Gota, Anthony P. Fernandez	5
10	Cells to Surgery Quiz: December 2017 2017 ·Journal of Investigative Dermatology ·Ali Rajabi‐Estarabadi, Natalie M. Williams, (unknown), (unknown), Samuel C. Smith, (unknown), (unknown), Fabrizio Galimberti, Keyvan Nouri	0
11	Increased, but Functionally Impaired, CD14+ HLA-DR–/low Myeloid-Derived Suppressor Cells in Psoriasis: A Mechanism of Dysregulated T Cells 2016 ·Journal of Investigative Dermatology ·David Soler, A. B. Young, (unknown), Fabrizio Galimberti, Sara M. Debanne, (unknown), Thomas S. McCormick, Kevin D. Cooper	27
12	All-trans-retinoic acid antagonizes the hedgehog pathway by inducing patched 2014 ·Cancer Biology & Therapy ·(unknown), Fabrizio Galimberti, (unknown), (unknown), David Sekula, Bin Li, Yongli Guo, James DiRenzo, Steven Fiering, Michael J. Spinella, David J. Robbins, Vincent A. Memoli, Sarah J. Freemantle, Ethan Dmitrovsky	10
13	Comparing Histone Deacetylase Inhibitor Responses in Genetically Engineered Mouse Lung Cancer Models and a Window of Opportunity Trial in Patients with Lung Cancer 2013 ·Molecular Cancer Therapeutics ·Tian Ma, Fabrizio Galimberti, Cherie P. Erkmen, Vincent A. Memoli, (unknown), Lorenzo F. Sempere, Jan H. Beumer, (unknown), William C. Nugent, David W. Johnstone, Gregory J. Tsongalis, Jonathan M. Kurie, Hua Li, James DiRenzo, Yongli Guo, Sarah J. Freemantle, Konstantin H. Dragnev, Ethan Dmitrovsky	20
14	Evidence for the Ubiquitin Protease UBP43 as an Antineoplastic Target 2012 ·Molecular Cancer Therapeutics ·Yongli Guo, (unknown), (unknown), Alexandra G. Lopez‐Aguiar, Yun Lu, Fabrizio Galimberti, Tian Ma, Qing Feng, David Sekula, Sarah J. Freemantle, Angeline S. Andrew, Vincent A. Memoli, Ethan Dmitrovsky	36
15	Bexarotene Plus Erlotinib Suppress Lung Carcinogenesis Independent of KRAS Mutations in Two Clinical Trials and Transgenic Models 2011 ·Cancer Prevention Research ·Konstantin H. Dragnev, Tian Ma, (unknown), Fabrizio Galimberti, Vincent A. Memoli, (unknown), Gregory J. Tsongalis, Marc Seltzer, David W. Johnstone, Cherie P. Erkmen, William C. Nugent, James R. Rigas, Xi Liu, Sarah J. Freemantle, Jonathan M. Kurie, Samuel Waxman, Ethan Dmitrovsky	40
16	Blockade of the Ubiquitin Protease UBP43 Destabilizes Transcription Factor PML/RARα and Inhibits the Growth of Acute Promyelocytic Leukemia 2010 ·Cancer Research ·Yongli Guo, (unknown), (unknown), Bruce A. Stanton, Jennifer M. Bomberger, Eugene Demidenko, (unknown), Robert E. Gallagher, Tian Ma, Fabrizio Galimberti, Xi Liu, David Sekula, Sarah J. Freemantle, Ethan Dmitrovsky	52
17	Targeting the Cyclin E-Cdk-2 Complex Represses Lung Cancer Growth by Triggering Anaphase Catastrophe 2009 ·Clinical Cancer Research ·Fabrizio Galimberti, (unknown), Xi Liu, Hua Li, Vincent A. Memoli, Simon R. Green, James DiRenzo, Patricia Greninger, Sreenath V. Sharma, Jeff Settleman, Duane A. Compton, Ethan Dmitrovsky	60
18	Uncovering Growth-Suppressive MicroRNAs in Lung Cancer 2009 ·Clinical Cancer Research ·Xi Liu, Lorenzo F. Sempere, Fabrizio Galimberti, Sarah J. Freemantle, Candice C. Black, Konstantin H. Dragnev, Yan Ma, Steven Fiering, Vincent A. Memoli, Hua Li, James DiRenzo, Murray Korc, Charles N. Cole, Mads Bak, Sakari Kauppinen, Ethan Dmitrovsky	151
19	UBE1L causes lung cancer growth suppression by targeting cyclin D1 2008 ·Molecular Cancer Therapeutics ·Qing Feng, David Sekula, Yongli Guo, Xi Liu, Candice C. Black, Fabrizio Galimberti, Sumit J. Shah, Lorenzo F. Sempere, Vincent A. Memoli, Jesper B. Andersen, Bret A. Hassel, Konstantin H. Dragnev, Ethan Dmitrovsky	73
20	Cyclin degradation for cancer therapy and chemoprevention 2007 ·Journal of Cellular Biochemistry ·Sarah J. Freemantle, Xi Liu, Qing Feng, Fabrizio Galimberti, (unknown), David Sekula, Sutisak Kitareewan, Konstantin H. Dragnev, Ethan Dmitrovsky	36

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact